The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial

Sung‐Min Won; Hyunchae Joung; I. Park; Sang Hak Han; Young Lim Ham; Ji-Sook Han; Yoojin Kwon; Dong Joon Kim; Ki Tae Suk

doi:10.1186/s12967-025-07478-z

Abstract

NCT04555434.

Affiliated Institutions

Related Publications

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella , Jeffrey V. Lazarus , Vlad Ratziu +50 more

The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to d...

2023 Journal of Hepatology 2166 citations

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

Mary E. Rinella , Jeffrey V. Lazarus , Vlad Ratziu +50 more

The principal limitations of the terms NAFLD and NASH are the reliance on exclusionary confounder terms and the use of potentially stigmatising language. This study set out to d...

2023 Hepatology 2323 citations

Empirical Evidence of Bias

Kenneth F. Schulz

<h3>Objective.</h3> —To determine if inadequate approaches to randomized controlled trial design and execution are associated with evidence of bias in estimating treatment effec...

1995 JAMA 5475 citations

How study design affects outcomes in comparisons of therapy. I: Medical

Graham A. Colditz , James N. Miller , Frederick Mosteller

Abstract We analysed 113 reports published in 1980 in a sample of medical journals to relate features of study design to the magnitude of gains attributed to new therapies over ...

1989 Statistics in Medicine 517 citations

Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study

Clara Depommier , Amandine Everard , Céline Druart +13 more

Metabolic syndrome is characterized by a constellation of comorbidities that predispose individuals to an increased risk of developing cardiovascular pathologies as well as type...

2019 Nature Medicine 2008 citations

Publication Info

Year: 2025
Type: article
Citations: 0
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

OpenAlex

Cite This

APA Style

                            
                                    Sung‐Min Won, 
                                
                                    Hyunchae Joung, 
                                
                                    I. Park
                                
                                et al.
                            
                            (2025). 
                            The effects of next generation probiotics on metabolic dysfunction-associated steatotic liver disease: a parallel, double-blind, randomized, placebo-controlled trial. 
                            Journal of Translational Medicine
                            
                            .
                            https://doi.org/10.1186/s12967-025-07478-z

Identifiers

DOI: 10.1186/s12967-025-07478-z